Skip to content

Clinical trials

Phase 2 Hematologic Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 2 Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20111
20121
20143
20151
20182
20213
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting2
Recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seagen Inc.4
Canadian Myeloma Research Group2
Cogent Biosciences, Inc.2
Novartis Pharmaceuticals2
Sierra Oncology LLC - a GSK company2
Biossil Inc.1
Chroma Therapeutics1
Forma Therapeutics, Inc.1
Hoffmann-La Roche1
National Heart, Lung, and Blood Institute (NHLBI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases18
Neoplasms5
Lymphoma4
Myeloproliferative Disorders4
Anemia, Sickle Cell3
Immune System Diseases3
Leukemia3
Leukemia, Myeloid3
Polycythemia Vera3
Anemia2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.